Minims (Oxybuprocaine Hydrochloride)

Oxybuprocaine Hydrochloride, the active ingredient in Minims, is a local anesthetic (ester type) presented as a sterile ophthalmic solution for ocular use. It provides rapid, reversible anesthesia of the ocular surface for diagnostic examinations and minor procedures. GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxybuprocaine Hydrochloride acts as a topical ocular anesthetic to temporarily block sensation on the eye surface. Diagnostic ocular examinations (e.g., slit‑lamp biomicroscopy): Provides rapid, reversible anesthesia of the ocular surface to facilitate patient comfort and accurate assessment. Minor ocular procedures (e.g., foreign body removal, tonometry): Enables painless manipulation of the eye during brief interventions. Laser ophthalmic procedures (e.g., photocoagulation): Allows temporary loss of sensation to reduce reflex tearing and eye movement.

Common Side Effects: - Transient burning or stinging sensation upon instillation. - Mild tearing or lacrimation. - Temporary blurred vision that resolves shortly after application.

Serious or Rare Side Effects: - Allergic contact dermatitis presenting as redness and itching. - Corneal epithelial toxicity leading to surface damage. - Severe ocular inflammation, including uveitis, in rare cases.

Oxybuprocaine Hydrochloride should be used under professional supervision and only for its intended ocular applications. Use only under professional supervision: ocular surface anesthesia should be administered by qualified eye‑care personnel. Avoid use in patients with known hypersensitivity to ester‑type anesthetics: discontinue if a reaction occurs. Limit exposure time: typically not exceeding the duration required for the procedure. Do not apply to compromised corneal epithelium unless directed: risk of delayed healing. Store at room temperature (below 25°C): keep in original container, protect from light and moisture.

Oxybuprocaine Hydrochloride may interact with other ocular agents and systemic medications. Major Interactions (Avoid): - Concurrent use with other ocular anesthetics: may increase risk of corneal toxicity. - Combination with topical vasoconstrictors (e.g., phenylephrine): may enhance local irritation.

Moderate Interactions (Monitor Closely): - Use with systemic sodium channel blockers (e.g., antiarrhythmics): monitor for additive effects. - Co‑administration with preservative‑containing eye drops: may increase ocular surface irritation. - Concurrent ocular surgery with prolonged exposure: monitor for delayed healing.